G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillPodcast
![]() |
Hear G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences. |
News
Biotech red hot in July as potential blockbuster M&A deals awake investors from their summer slumber August 01, 2008 | Press Release
Biotech remains upbeat in wake of market turmoil July 01, 2008 | Press Release
Genetic test industry faces tough challenges with consumers, survey finds June 17, 2008 | Press Release
See all News
James D. Watson
Managing Director and Head of Merchant BankingMr. Watson has broad therapeutic and drug discovery experience in strategy and partnership formation. Prior to joining Burrill & Company, he was a Senior VP with Incyte Genomics heading the Business Development and Marketing organizations. Before Incyte, he was General Manager and previously VP Business Development for Chemdex, a pioneering marketplace for research scientists with over 100 employees. Prior to Chemdex, Mr. Watson was Head of the San Francisco office of The Wilkerson Group where he built the office from 4 to over 30 consultants. Earlier, he gained operational experience with Lilly in Indianapolis and the UK in a variety of new product development and commercially focused roles. Mr. Watson received a Fulbright Scholarship and MBA from Indiana University and lectured in Economics at Portsmouth University, England.

.jpg)
.jpg)